Sinopharm Group Co. Ltd.

OTC: SHTDY · Real-Time Price · USD
12.42
0.10 (0.77%)
At close: Aug 15, 2025, 12:49 PM

Sinopharm Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
14B 19.51B 18.56B 17B
Depreciation & Amortization
4.73B 4.43B 4.17B 3.92B
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
12.94B 10.53B 7.43B -7.76B
Other Non-Cash Items
-717.87M -2.9B 308.65M 484.2M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-6.47B -3.86B -2.07B -12.1B
Operating Cash Flow
11.55B 17.17B 20.96B 9.31B
Capital Expenditures
-1.97B -2.34B -2.42B -2.26B
Cash Acquisitions
-121.78M -31.86M -336.71M -488.36M
Purchase of Investments
n/a -29.07M -100M -75M
Sales Maturities Of Investments
5.71M 53.06M 211.53M 298.63M
Other Investing Acitivies
-1.93B 1.02B -946.91M 1.25B
Investing Cash Flow
-3.75B -944.53M -3.59B -1.27B
Debt Repayment
-7.73B 385.68M 4.75B -6.54B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-2.71B -2.56B -2.34B -2.15B
Other Financial Acitivies
-6.84B -5.47B -8.1B -6B
Financial Cash Flow
-17.29B -7.64B -5.69B -14.69B
Net Cash Flow
-9.5B 8.59B 11.69B -6.65B
Free Cash Flow
9.58B 14.84B 18.55B 7.05B